Search research articles
Contact Us
Filters
Showing results (261-270 of 277) with videos related to
Page
of 28
Sort By:
Cancer Cell
|
October 29, 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Nature Cancer
|
August 18, 2020
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Ehsan Ghorani, James L Reading, Jake Y Henry, et al.
Nature Communications
|
September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
Marcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)
Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Nature
|
April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
NPJ Breast Cancer
|
December 2, 2021
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi, Harry R Haynes, Elizabeth Blackley, et al.
NPJ Breast Cancer
|
May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
The Journal of Pathology
|
March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Nature
|
July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx
Alexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature
|
April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERx
Alexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 277) with videos related to
Sort By:
Page
of 28
Cancer Cell
|
October 29, 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma
Lewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Nature Cancer
|
August 18, 2020
The T cell differentiation landscape is shaped by tumour mutations in lung cancer
Ehsan Ghorani, James L Reading, Jake Y Henry, et al.
Nature Communications
|
September 27, 2016
Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration
Marcel Smid, F Germán Rodríguez-González, Anieta M Sieuwerts, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)
Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Nature
|
April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
NPJ Breast Cancer
|
December 2, 2021
The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
Khalid El Bairi, Harry R Haynes, Elizabeth Blackley, et al.
NPJ Breast Cancer
|
May 16, 2020
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
Mohamed Amgad, Elisabeth Specht Stovgaard, Eva Balslev, et al.
The Journal of Pathology
|
March 5, 2020
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, et al.
Nature
|
July 4, 2024
Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx
Alexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Nature
|
April 12, 2023
The evolution of lung cancer and impact of subclonal selection in TRACERx
Alexander M Frankell, Michelle Dietzen, Maise Al Bakir, et al.
Page
of 28